ovalbumin and kutkin

The present study was envisaged to evaluate potential of combination therapy comprising of immunomodulator picroliv and antimalarial chloroquine against drug resistant Plasmodium yoelii (P. yoelii) infection in BALB/c mice.. The immunomodulatory potential of picroliv was established by immunizing animals with model antigen along with picroliv. Immune response was assessed using T-cell proliferation assay and also by determining the antibody isotype-profile induced in the immunized mice. In the next set of experiment, prophylactic potential of picroliv to strengthen antimalarial properties of chloroquine against P. yoelii (MDR) infection in BALB/c mice was assessed.. T-cell proliferation as well as antibody production study reveals that picroliv helps in evoking strong immuno-potentiating response against model antigen in the immunized mice. Co-administration of picroliv enhances efficacy of CHQ against experimental murine malaria.. The activation of host immune system can increase the efficacy of chloroquine for suppression of drug resistant malaria infection in BALB/c mice.

Topics: Animals; Antimalarials; B7-1 Antigen; B7-2 Antigen; Chloroquine; Cinnamates; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycosides; Immunoglobulin G; Immunologic Factors; Lymphocyte Activation; Macrophages; Malaria; Mice; Mice, Inbred BALB C; Ovalbumin; Plasmodium yoelii; Reactive Oxygen Species; T-Lymphocytes; Time Factors; Up-Regulation; Vanillic Acid